Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Early KLRG1+ but Not CD57+CD8+ T Cells in Primary Cytomegalovirus Infection Predict Effector Function and Viral Control.

Hoji A, Popescu ID, Pipeling MR, Shah PD, Winters SA, McDyer JF.

J Immunol. 2019 Oct 15;203(8):2063-2075. doi: 10.4049/jimmunol.1900399. Epub 2019 Sep 25.

PMID:
31554693
2.

GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis.

Zhang Y, Jiang M, Nouraie M, Roth MG, Tabib T, Winters S, Chen X, Sembrat J, Chu Y, Cardenes N, Tuder RM, Herzog EL, Ryu C, Rojas M, Lafyatis R, Gibson KF, McDyer JF, Kass DJ, Alder JK.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L510-L521. doi: 10.1152/ajplung.00062.2019. Epub 2019 Aug 21.

3.

Aerosolization of second-generation triazoles: In vitro evaluation and application in therapy of invasive airway aspergillosis.

Thanukrishnan H, Corcoran TE, Iasella CJ, Moore CA, Nero JA, Morrell MR, McDyer JF, Hussain S, Nguyen MH, Venkataramanan R, Ensor CR.

Transplantation. 2019 Mar 4. doi: 10.1097/TP.0000000000002697. [Epub ahead of print]

PMID:
31343565
4.

Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.

Wang X, O'Brien ME, Yu J, Xu C, Zhang Q, Lu S, Liang L, An X, McDyer JF, Mallampalli RK.

Am J Respir Cell Mol Biol. 2019 Aug;61(2):244-256. doi: 10.1165/rcmb.2018-0207OC.

PMID:
30742487
5.

Jejuno-jejunal intussusception in a post-lung transplant patient from a gastrojejunostomy tube: A case report.

Harano T, Sanchez PG, Bauza G, McDyer JF, D'Cunha J.

Int J Surg Case Rep. 2019;55:129-131. doi: 10.1016/j.ijscr.2019.01.034. Epub 2019 Jan 31.

6.

Cytokine-targeted therapy for the management of solid organ transplant recipients.

Szczepanik A, Iasella CJ, McDyer JF, Ensor CR.

Hum Immunol. 2019 Mar;80(3):184-190. doi: 10.1016/j.humimm.2018.12.006. Epub 2018 Dec 16. Review.

PMID:
30562564
7.

Foxp3+ T lymphocytes: immune regulators within the lung allograft.

Lendermon EA, McDyer JF.

J Clin Invest. 2019 Feb 1;129(2):494-495. doi: 10.1172/JCI126517. Epub 2018 Dec 18.

8.

Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation.

Lichvar AB, Ensor CR, Zeevi A, Morrell MR, Pilewski JM, Hayanga JWA, D'Cunha J, McDyer JF, Petrov AA.

Prog Transplant. 2018 Dec 11:1526924818817028. doi: 10.1177/1526924818817028. [Epub ahead of print]

PMID:
30537897
9.

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.

Popescu I, Mannem H, Winters SA, Hoji A, Silveira F, McNally E, Pipeling MR, Lendermon EA, Morrell MR, Pilewski JM, Hanumanthu VS, Zhang Y, Gulati S, Shah PD, Iasella CJ, Ensor CR, Armanios M, McDyer JF.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):362-376. doi: 10.1164/rccm.201805-0825OC.

PMID:
30088779
10.

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier.

Ensor CR, Goehring KC, Iasella CJ, Moore CA, Lendermon EA, McDyer JF, Morrell MR, Sciortino CM, Venkataramanan R, Wiland AM.

Clin Transplant. 2018 Oct;32(10):e13363. doi: 10.1111/ctr.13363. Epub 2018 Sep 10. Review.

PMID:
30058177
11.

Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet-/- Mouse Lung Allograft Recipients.

Lendermon EA, Dodd-O JM, Coon TA, Wang X, Ensor CR, Cardenes N, Koodray CL, Heusey HL, Bennewitz MF, Sundd P, Bullock GC, Popescu I, Guo L, O'Donnell CP, Rojas M, McDyer JF.

Transplant Proc. 2018 Jun;50(5):1566-1574. doi: 10.1016/j.transproceed.2018.02.070. Epub 2018 Mar 9.

PMID:
29880387
12.

Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.

Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR.

Clin Transplant. 2018 May;32(5):e13235. doi: 10.1111/ctr.13235. Epub 2018 Mar 30.

13.

Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients.

Ensor CR, Iasella CJ, Harrigan KM, Morrell MR, Moore CA, Shigemura N, Zeevi A, McDyer JF, Venkataramanan R.

Am J Transplant. 2018 Jun;18(6):1527-1533. doi: 10.1111/ajt.14723. Epub 2018 Apr 6.

14.

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Porteous MK, Lee JC, Lederer DJ, Palmer SM, Cantu E, Shah RJ, Bellamy SL, Lama VN, Bhorade SM, Crespo MM, McDyer JF, Wille KM, Localio AR, Orens JB, Shah PD, Weinacker AB, Arcasoy S, Wilkes DS, Ware LB, Christie JD, Kawut SM, Diamond JM; Lung Transplant Outcomes Group.

Ann Am Thorac Soc. 2017 Oct;14(10):1514-1522. doi: 10.1513/AnnalsATS.201610-810OC.

15.

Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.

Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, Hayanga JWA, Lendermon EA, Zeevi A, McDyer JF, Ensor CR.

Transplantation. 2018 Jan;102(1):171-177. doi: 10.1097/TP.0000000000001873.

PMID:
28691954
16.

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation.

Lendermon EA, Coon TA, Bednash JS, Weathington NM, McDyer JF, Mallampalli RK.

Respir Res. 2017 Jun 28;18(1):131. doi: 10.1186/s12931-017-0608-8.

17.

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Lama VN, Belperio JA, Christie JD, El-Chemaly S, Fishbein MC, Gelman AE, Hancock WW, Keshavjee S, Kreisel D, Laubach VE, Looney MR, McDyer JF, Mohanakumar T, Shilling RA, Panoskaltsis-Mortari A, Wilkes DS, Eu JP, Nicolls MR.

JCI Insight. 2017 May 4;2(9). pii: 93121. doi: 10.1172/jci.insight.93121. eCollection 2017 May 4. Review.

18.

Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Presti RM, Flores SC, Palmer BE, Atkinson JJ, Lesko CR, Lau B, Fontenot AP, Roman J, McDyer JF, Twigg HL 3rd.

Chest. 2017 Nov;152(5):1053-1060. doi: 10.1016/j.chest.2017.04.154. Epub 2017 Apr 17. Review.

19.

Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.

Moore CA, Pilewski JM, Venkataramanan R, Robinson KM, Morrell MR, Wisniewski SR, Zeevi A, McDyer JF, Ensor CR.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12688. Epub 2017 Apr 17.

PMID:
28273385
20.

Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.

Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, D'Cunha J, Wisniewski SR, Venkataramanan R, Zeevi A, McDyer JF.

Am J Transplant. 2017 May;17(5):1380-1388. doi: 10.1111/ajt.14222. Epub 2017 Mar 9.

21.

Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.

Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, Pilewski JM, Wisniewski S, Johnson BA, D'Cunha J, Zeevi A, McDyer JF.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12899. Epub 2017 Feb 22.

PMID:
28008661
22.

Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?

Moore CA, Iasella CJ, Venkataramanan R, Lakkis FG, Smith RB, McDyer JF, Zeevi A, Ensor CR.

Hum Immunol. 2017 Feb;78(2):64-71. doi: 10.1016/j.humimm.2016.12.005. Epub 2016 Dec 18. Review.

PMID:
27998802
23.

Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.

Dodd-O JM, Ganguly S, Vulic A, Panoskaltsis-Mortari A, McDyer JF, Luznik L.

Transplantation. 2016 Dec;100(12):e140-e146. doi: 10.1097/TP.0000000000001480.

24.

HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.

Popescu I, Drummond MB, Gama L, Lambert A, Hoji A, Coon T, Merlo CA, Wise RA, Keruly J, Clements JE, Kirk GD, McDyer JF.

J Infect Dis. 2016 Nov 15;214(10):1520-1530. Epub 2016 Sep 9.

25.

Evaluation of Direct Oral Anticoagulation Therapy in Heart and Lung Transplant Recipients.

Lichvar AB, Moore CA, Ensor CR, McDyer JF, Teuteberg JJ, Shullo MA.

Prog Transplant. 2016 Sep;26(3):263-9. doi: 10.1177/1526924816661951. Review.

PMID:
27597772
26.

IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.

Popescu I, Pipeling MR, Mannem H, Shah PD, Orens JB, Connors M, Migueles SA, McDyer JF.

J Immunol. 2016 Jan 15;196(2):877-90. doi: 10.4049/jimmunol.1501589. Epub 2015 Dec 11.

27.

Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis.

Shah PD, Zhong Q, Lendermon EA, Pipeling MR, McDyer JF.

Viral Immunol. 2015 Jun;28(5):255-64. doi: 10.1089/vim.2015.0005. Epub 2015 May 18.

28.

Serial monitoring of exhaled nitric oxide in lung transplant recipients.

Gashouta MA, Merlo CA, Pipeling MR, McDyer JF, Hayanga JW, Orens JB, Girgis RE.

J Heart Lung Transplant. 2015 Apr;34(4):557-62. doi: 10.1016/j.healun.2014.09.026. Epub 2014 Nov 6.

29.

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.

Morrell MR, Pilewski JM, Gries CJ, Pipeling MR, Crespo MM, Ensor CR, Yousem SA, D'Cunha J, Shigemura N, Bermudez CA, McDyer JF, Zeevi A.

J Heart Lung Transplant. 2014 Dec;33(12):1288-94. doi: 10.1016/j.healun.2014.07.018. Epub 2014 Aug 23.

PMID:
25443870
30.

T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.

Popescu I, Pipeling MR, Shah PD, Orens JB, McDyer JF.

J Immunol. 2014 Dec 1;193(11):5709-5722. doi: 10.4049/jimmunol.1401436. Epub 2014 Oct 22.

31.

CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.

Lendermon EA, Dodd-o JM, Coon TA, Miller HL, Ganguly S, Popescu I, O'Donnell CP, Cardenes N, Levine M, Rojas M, Weathington NM, Zhao J, Zhao Y, McDyer JF.

Am J Respir Cell Mol Biol. 2015 May;52(5):622-33. doi: 10.1165/rcmb.2014-0059OC.

32.

Infections in the immunosuppressed host.

George MP, Masur H, Norris KA, Palmer SM, Clancy CJ, McDyer JF.

Ann Am Thorac Soc. 2014 Aug;11 Suppl 4:S211-20. doi: 10.1513/AnnalsATS.201401-038PL. Review.

33.

Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.

Popescu I, Drummond MB, Gama L, Coon T, Merlo CA, Wise RA, Clements JE, Kirk GD, McDyer JF.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):744-55. doi: 10.1164/rccm.201407-1226OC.

34.

Domperidone for delayed gastric emptying in lung transplant recipients with and without gastroesophageal reflux.

Lidor AO, Ensor CR, Sheer AJ, Orens JB, Clarke JO, McDyer JF.

Prog Transplant. 2014 Mar;24(1):27-32. doi: 10.7182/pit2014823.

PMID:
24598562
35.

Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.

Miller HL, Shah PD, Orens JB, McDyer JF.

J Heart Lung Transplant. 2013 Sep;32(9):914-24. doi: 10.1016/j.healun.2013.06.017.

36.

The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort.

Drummond MB, Merlo CA, Astemborski J, Kalmin MM, Kisalu A, Mcdyer JF, Mehta SH, Brown RH, Wise RA, Kirk GD.

AIDS. 2013 May 15;27(8):1303-11. doi: 10.1097/QAD.0b013e32835e395d.

37.

High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.

Akulian JA, Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.

Am J Transplant. 2013 Jan;13(1):146-56. doi: 10.1111/j.1600-6143.2012.04282.x. Epub 2012 Sep 27.

38.

Pentraxin 3 in primary graft dysfunction: the long and short of it.

Zhang Y, McDyer JF.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):475-7. doi: 10.1164/rccm.201207-1158ED. No abstract available.

PMID:
22984023
39.

F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.

Chen BB, Glasser JR, Coon TA, Zou C, Miller HL, Fenton M, McDyer JF, Boyiadzis M, Mallampalli RK.

Blood. 2012 Mar 29;119(13):3132-41. doi: 10.1182/blood-2011-06-358911. Epub 2012 Feb 8.

40.

Association between obstructive lung disease and markers of HIV infection in a high-risk cohort.

Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, Brown RH, Wise RA, Merlo CA.

Thorax. 2012 Apr;67(4):309-14. doi: 10.1136/thoraxjnl-2011-200702. Epub 2011 Nov 16.

41.

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.

Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.

J Infect Dis. 2011 Dec 1;204(11):1663-71. doi: 10.1093/infdis/jir624. Epub 2011 Oct 21.

42.

CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant.

Dodd-o JM, Lendermon EA, Miller HL, Zhong Q, John ER, Jungraithmayr WM, D'Alessio FR, McDyer JF.

Am J Transplant. 2011 Sep;11(9):1815-24. doi: 10.1111/j.1600-6143.2011.03623.x. Epub 2011 Aug 9.

43.

Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Drummond MB, Kirk GD, Ricketts EP, McCormack MC, Hague JC, McDyer JF, Mehta SH, Engels EA, Wise RA, Merlo CA.

BMC Pulm Med. 2010 May 11;10:27. doi: 10.1186/1471-2466-10-27.

44.

Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP.

Am J Epidemiol. 2010 May 15;171(10):1144-52. doi: 10.1093/aje/kwq062. Epub 2010 Apr 16.

45.

Viral infections in lung transplant recipients.

Shah PD, McDyer JF.

Semin Respir Crit Care Med. 2010 Apr;31(2):243-54. doi: 10.1055/s-0030-1249120. Epub 2010 Mar 30. Review.

46.

CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration.

Shah PD, West EE, Whitlock AB, Orens JB, McDyer JF.

Am J Transplant. 2009 Dec;9(12):2697-706. doi: 10.1111/j.1600-6143.2009.02805.x.

47.

CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, Pipeling MR, Brower RG, Tuder RM, McDyer JF, King LS.

J Clin Invest. 2009 Oct;119(10):2898-913. doi: 10.1172/JCI36498. Epub 2009 Sep 21.

48.

Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT Jr, Connors M, Migueles SA.

J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.

49.

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, Grunewald J, Moller DR.

J Immunol. 2008 Dec 15;181(12):8784-96.

50.

Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Pipeling MR, West EE, Osborne CM, Whitlock AB, Dropulic LK, Willett MH, Forman M, Valsamakis A, Orens JB, Moller DR, Lechtzin N, Migueles SA, Connors M, McDyer JF.

J Immunol. 2008 Jul 1;181(1):546-56.

Supplemental Content

Loading ...
Support Center